IN THE NEWS
Mayne Pharma Announces Strategic investment in US Facilities
Metrics Contract Services Appoints Manager of Pharmaceutical Development
Metrics Contract Services, the contract pharmaceutical development and manufacturing division of Mayne Pharma, welcomes Troy Stox as manager of pharmaceutical development.
Metrics Contract Services Adds Bosch GKF-702 Encapsulator
Metrics Contract Services, a division of Mayne Pharma Group Limited, has added a Bosch GKF-702 capsule filling machine to its recently completed solid oral dose commercial manufacturing facility in Greenville, North Carolina, USA.
Metrics Contract Services Appoints Manager of Pharmaceutical Development Metrics Contract Services Announces Serialization Capabilities at Greenville Site Metrics Contract Services Continues Strong Focus on First-Time-In-Man and Phase I Services Metrics Contract Services Appoints Associate Director of Pharmaceutical Development
Metrics Contract Services Announces Serialization Capabilities at Greenville Site
Metrics announces successful qualification of two commercial bottling lines for serialization at its new US$80 million oral solid dose commercial manufacturing site.
Metrics Adds Commercial Gerteis Roller Compaction Capabilities
Metrics has added a Gerteis Mini-Pactor® roller compactor to its granulation capabilities at its new US$80 million oral solid dose commercial manufacturing facility in Greenville, North Carolina.
Sample Submission Request Form
Sending a sample to Metrics? Use this form to record your sample, storage and testing information...
Our Continued Focus on FTIM and Phase I Services
For over 20 years, Metrics’ pharmaceutical development services have been growing, offering expanding capacities, capabilities, and manufacturing processes for small molecule oral solid dosage forms. And through it all, Metrics continues to invest in equipment and resources to support a healthy foundation of business in the First-time-in-Man and Phase I space.
Metrics is excited to share our upcoming events calendar. Connect with us at a meeting or conference in 2019 to learn more about our new offerings and what they mean for your next project.
Take a Look at Our New $80-Million Oral Solid Dose Manufacturing Facility
With the added capacity of this new 126,000-square-foot facility, our development clients can keep their projects in one contiguous location under one site registration. Watch our video and see for yourself.